vs
California BanCorp \ CA（BCAL）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是California BanCorp \ CA的1.6倍（$75.5M vs $45.9M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 0.8%），California BanCorp \ CA自由现金流更多（$56.9M vs $14.4M），过去两年California BanCorp \ CA的营收复合增速更高（44.7% vs 31.3%）
太平洋第一控股是依据美国1956年银行控股公司法案成立的美国银行控股集团，总部位于加利福尼亚州欧文市。集团核心业务围绕旗下太平洋第一银行展开，为个人、企业及专业人士提供各类金融服务，目前在加州、亚利桑那州、内华达州和华盛顿州开设了多家网点。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
BCAL vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.6倍
$45.9M
营收增速更快
PBYI
高出26.9%
0.8%
自由现金流更多
BCAL
多$42.6M
$14.4M
两年增速更快
BCAL
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.9M | $75.5M |
| 净利润 | $16.4M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 48.8% | 22.7% |
| 净利率 | 35.8% | — |
| 营收同比 | 0.8% | 27.7% |
| 净利润同比 | -2.1% | — |
| 每股收益（稀释后） | $0.50 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCALPBYI
| Q4 25 | $45.9M | $75.5M | ||
| Q3 25 | $45.2M | $54.5M | ||
| Q2 25 | $44.3M | $52.4M | ||
| Q1 25 | $44.8M | $46.0M | ||
| Q4 24 | $45.5M | $59.1M | ||
| Q3 24 | $38.1M | $80.5M | ||
| Q2 24 | $22.2M | $47.1M | ||
| Q1 24 | $21.9M | $43.8M |
净利润BCALPBYI
| Q4 25 | $16.4M | — | ||
| Q3 25 | $15.7M | $8.8M | ||
| Q2 25 | $14.1M | $5.9M | ||
| Q1 25 | $16.9M | $3.0M | ||
| Q4 24 | $16.8M | — | ||
| Q3 24 | $-16.5M | $20.3M | ||
| Q2 24 | $190.0K | $-4.5M | ||
| Q1 24 | $4.9M | $-4.8M |
毛利率BCALPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率BCALPBYI
| Q4 25 | 48.8% | 22.7% | ||
| Q3 25 | 48.3% | 17.6% | ||
| Q2 25 | 45.3% | 12.7% | ||
| Q1 25 | 52.8% | 8.7% | ||
| Q4 24 | 52.2% | 22.6% | ||
| Q3 24 | -59.1% | 27.4% | ||
| Q2 24 | 1.3% | -4.6% | ||
| Q1 24 | 33.1% | -5.3% |
净利率BCALPBYI
| Q4 25 | 35.8% | — | ||
| Q3 25 | 34.7% | 16.2% | ||
| Q2 25 | 31.8% | 11.2% | ||
| Q1 25 | 37.6% | 6.5% | ||
| Q4 24 | 37.7% | — | ||
| Q3 24 | -43.2% | 25.2% | ||
| Q2 24 | 0.9% | -9.6% | ||
| Q1 24 | 22.5% | -11.0% |
每股收益（稀释后）BCALPBYI
| Q4 25 | $0.50 | $0.26 | ||
| Q3 25 | $0.48 | $0.17 | ||
| Q2 25 | $0.43 | $0.12 | ||
| Q1 25 | $0.52 | $0.06 | ||
| Q4 24 | $0.54 | $0.40 | ||
| Q3 24 | $-0.59 | $0.41 | ||
| Q2 24 | $0.01 | $-0.09 | ||
| Q1 24 | $0.26 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $399.9M | $97.5M |
| 总债务越低越好 | $33.8M | $22.7M |
| 股东权益账面价值 | $576.6M | $130.3M |
| 总资产 | $4.0B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.06× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资BCALPBYI
| Q4 25 | $399.9M | $97.5M | ||
| Q3 25 | $559.2M | $94.4M | ||
| Q2 25 | $430.1M | $96.0M | ||
| Q1 25 | $439.2M | $93.2M | ||
| Q4 24 | $388.2M | $101.0M | ||
| Q3 24 | $614.4M | $96.7M | ||
| Q2 24 | $104.7M | $96.8M | ||
| Q1 24 | $86.5M | $107.2M |
总债务BCALPBYI
| Q4 25 | $33.8M | $22.7M | ||
| Q3 25 | $33.4M | $34.0M | ||
| Q2 25 | $52.9M | $45.3M | ||
| Q1 25 | $70.3M | $56.7M | ||
| Q4 24 | $69.7M | $68.0M | ||
| Q3 24 | $69.1M | $79.3M | ||
| Q2 24 | $42.9M | $90.7M | ||
| Q1 24 | $44.9M | $102.0M |
股东权益BCALPBYI
| Q4 25 | $576.6M | $130.3M | ||
| Q3 25 | $564.7M | $115.3M | ||
| Q2 25 | $547.6M | $104.7M | ||
| Q1 25 | $531.4M | $97.1M | ||
| Q4 24 | $511.8M | $92.1M | ||
| Q3 24 | $498.1M | $71.1M | ||
| Q2 24 | $293.2M | $48.5M | ||
| Q1 24 | $292.5M | $51.0M |
总资产BCALPBYI
| Q4 25 | $4.0B | $216.3M | ||
| Q3 25 | $4.1B | $202.9M | ||
| Q2 25 | $4.0B | $194.9M | ||
| Q1 25 | $4.0B | $196.2M | ||
| Q4 24 | $4.0B | $213.3M | ||
| Q3 24 | $4.4B | $220.7M | ||
| Q2 24 | $2.3B | $205.0M | ||
| Q1 24 | $2.3B | $214.1M |
负债/权益比BCALPBYI
| Q4 25 | 0.06× | 0.17× | ||
| Q3 25 | 0.06× | 0.30× | ||
| Q2 25 | 0.10× | 0.43× | ||
| Q1 25 | 0.13× | 0.58× | ||
| Q4 24 | 0.14× | 0.74× | ||
| Q3 24 | 0.14× | 1.12× | ||
| Q2 24 | 0.15× | 1.87× | ||
| Q1 24 | 0.15× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $56.9M | $14.4M |
| 自由现金流率自由现金流/营收 | 124.1% | 19.1% |
| 资本支出强度资本支出/营收 | 0.8% | 0.0% |
| 现金转化率经营现金流/净利润 | 3.49× | — |
| 过去12个月自由现金流最近4个季度 | $93.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流BCALPBYI
| Q4 25 | $57.3M | $14.4M | ||
| Q3 25 | $16.0M | $9.7M | ||
| Q2 25 | $13.4M | $14.1M | ||
| Q1 25 | $7.0M | $3.6M | ||
| Q4 24 | $50.3M | $15.6M | ||
| Q3 24 | $18.3M | $11.0M | ||
| Q2 24 | $309.0K | $1.0M | ||
| Q1 24 | $8.1M | $11.2M |
自由现金流BCALPBYI
| Q4 25 | $56.9M | $14.4M | ||
| Q3 25 | $15.9M | $9.7M | ||
| Q2 25 | $13.4M | $14.1M | ||
| Q1 25 | $6.9M | $3.6M | ||
| Q4 24 | $49.7M | $15.6M | ||
| Q3 24 | $18.1M | $11.0M | ||
| Q2 24 | $171.0K | $1.0M | ||
| Q1 24 | $8.0M | — |
自由现金流率BCALPBYI
| Q4 25 | 124.1% | 19.1% | ||
| Q3 25 | 35.1% | 17.7% | ||
| Q2 25 | 30.2% | 26.8% | ||
| Q1 25 | 15.3% | 7.7% | ||
| Q4 24 | 109.2% | 26.4% | ||
| Q3 24 | 47.5% | 13.7% | ||
| Q2 24 | 0.8% | 2.1% | ||
| Q1 24 | 36.4% | — |
资本支出强度BCALPBYI
| Q4 25 | 0.8% | 0.0% | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | 1.2% | 0.0% | ||
| Q3 24 | 0.5% | 0.0% | ||
| Q2 24 | 0.6% | 0.0% | ||
| Q1 24 | 0.4% | 0.0% |
现金转化率BCALPBYI
| Q4 25 | 3.49× | — | ||
| Q3 25 | 1.02× | 1.10× | ||
| Q2 25 | 0.95× | 2.41× | ||
| Q1 25 | 0.41× | 1.21× | ||
| Q4 24 | 3.00× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | 1.63× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
